Gene · 779
Papers2,128
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,128
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gating pore currents occur in CaV1.1 domain III mutants associated with HypoPP. | J Gen Physiol | 2021 | 34463712 | PubTator, text mining | PubMed |
| Sequence variants in malignant hyperthermia genes in Iceland: classification and actionable findings in a population database. | Eur J Hum Genet | 2021 | 34462577 | PubTator, text mining | PubMed |
| Role of High Voltage-Gated Ca2+ Channel Subunits in Pancreatic β-Cell Insulin Release. From Structure to Function. | Cells | 2021 | 34440773 | PubTator, text mining | PubMed |
| An Integrated Clinical-Biological Approach to Identify Interindividual Variability and Atypical Phenotype-Genotype Correlations in Myopathies: Experience on A Cohort of 156 Families. | Genes (Basel) | 2021 | 34440373 | PubTator, text mining | PubMed |
| Pathological Mechanism of a Constitutively Active Form of Stromal Interaction Molecule 1 in Skeletal Muscle. | Biomolecules | 2021 | 34439731 | PubTator, text mining | PubMed |
| The Dragon's Paralysing Spell: Evidence of Sodium and Calcium Ion Channel Binding Neurotoxins in Helodermatid and Varanid Lizard Venoms. | Toxins (Basel) | 2021 | 34437420 | PubTator, text mining | PubMed |
| L-Type Calcium Channel: Predicting Pathogenic/Likely Pathogenic Status for Variants of Uncertain Clinical Significance. | Membranes (Basel) | 2021 | 34436362 | PubTator, text mining | PubMed |
| Differential effects of eplerenone versus amlodipine on muscle metaboreflex function in hypertensive humans. | J Clin Hypertens (Greenwich) | 2021 | 34432358 | PubTator, text mining | PubMed |
| Malignant Hyperthermia Syndrome: A Clinical Case Report. | EJIFCC | 2021 | 34421497 | PubTator, text mining | PubMed |
| Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort study. | BMC Med | 2021 | 34404389 | PubTator, text mining | PubMed |
| Appraisal and development of evidence-based clinical decision support to enable perioperative pharmacogenomic application. | Pharmacogenomics J | 2021 | 34376788 | PubTator, text mining | PubMed |
| Male Infertility Knowledgebase: decoding the genetic and disease landscape. | Database (Oxford) | 2021 | 34363073 | PubTator, text mining | PubMed |
| Computational Analysis of the Crystal and Cryo-EM Structures of P-Loop Channels with Drugs. | Int J Mol Sci | 2021 | 34360907 | PubTator, text mining | PubMed |
| Pathophysiological Effects of Overactive STIM1 on Murine Muscle Function and Structure. | Cells | 2021 | 34359900 | PubTator, text mining | PubMed |
| Identification by MicroRNA Analysis of Environmental Risk Factors Bearing Pathogenic Relevance in Non-Smoker Lung Cancer. | J Pers Med | 2021 | 34357133 | PubTator, text mining | PubMed |
| Structural and functional interactions between the Ca2+-, ATP-, and caffeine-binding sites of skeletal muscle ryanodine receptor (RyR1). | J Biol Chem | 2021 | 34352272 | PubTator, text mining | PubMed |
| Sympathetic modulation by antihypertensive drugs. | J Clin Hypertens (Greenwich) | 2021 | 34343397 | PubTator, text mining | PubMed |
| Quantitative disease risk scores from EHR with applications to clinical risk stratification and genetic studies. | NPJ Digit Med | 2021 | 34302027 | PubTator, text mining | PubMed |
| Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation. | Int J Mol Sci | 2021 | 34299191 | PubTator, text mining | PubMed |
| Confirming Genetic Abnormalities of Hypokalemic Periodic Paralysis Using Next-Generation Sequencing: A Case Report and Literature Review. | Electrolyte Blood Press | 2021 | 34290819 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/779/papers?page=29